Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
Heart Failure Symposium 2023
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
European Society of Cardiology Congress – Amsterdam 2020
August 29, 2020 @ 8:00 am - September 2, 2020 @ 5:00 pm EDT
ESC Congress brings together more than 33,000 dedicated colleagues to share, challenge and learn from each other.
Under one roof – over five days – the Congress Programme Committee assembles the very latest cardiovascular science and innovation. Where else can you find more than 500 sessions and 4,500 presentations with such a world-renowned faculty?
And you can choose from a range of educational formats: Late-Breaking Science Sessions, Case-Based Sessions, Guidelines Presentations, and two rapidly growing favourites: How Should I Treat, and the Focus with the Experts Sessions.
The Spotlight theme for ESC Congress 2020 is “The Cutting Edge of Cardiology”, featuring specific sessions on the latest technology in clinical cardiology available today and on the horizon.
ESC Congress, beyond its commitment for excellence in science and education, is an opportunity to inspire. It is first and foremost a celebration of discovery unlike any other.